After 21 days, BW increased by 2.6% 0.71% in V rats and was reduced in the other cohorts by 8.7% 0.91% (CS), 5.6% 0.50% (PF) or 9.0% 0.42% (WM) (all P 3 C)
Protocol 3: fatigue and cognitive dysfunction focus (intermediate) Goal: Address crushing fatigue and fibro fog as primary concerns Peptides: CJC-1295 + Ipamorelin : 100mcg each before bed Semax : 400mcg intranasal morning BPC-157 : 250mcg twice daily for baseline support Duration: 12 weeks Why this works: GH peptides address sleep architecture underlying fatigue
Products are not intended for human use or consumption of any kind
May support improved tissue function by reducing the senescence-associated secretory phenotype (SASP)
Cell migration and repair signalling
The increased pressure in the superior sagittal sinus, portal and caval hypertension, aortal hypotension, arterial and venous thrombosis, severe brain swelling and lesions (cortex (cerebral, cerebellar), hypothalamus/thalamus, hippocampus), particular veins (azygos, superior mesenteric, inferior caval) dysfunction, heart dysfunction, lung congestion as acute respiratory distress syndrome, kidney disturbances, liver failure, and hemorrhagic lesions in gastrointestinal tract were all assessed